Assembly Biosciences Inc (ASMB) support and resistance · rev $21.6M
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
This page maps Assembly Biosciences Inc (ASMB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
ASMB currently screens at market cap $143.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ASMB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ASMB quote page for the session range and the stock page for the full model.
Not investment advice.